Aevi Genomic Medicine, Inc. 4
4 · Aevi Genomic Medicine, Inc. · Filed Mar 27, 2017
Insider Transaction Report
Form 4
HARPER PHILIP R
10% Owner
Transactions
- Purchase
Common Stock
2017-03-22$1.79/sh+1,000,000$1,790,000→ 4,786,682 total - Purchase
Common Stock
2017-03-24$1.60/sh+53,826$86,122→ 4,845,213 total - Purchase
Common Stock
2017-03-23$1.60/sh+4,705$7,528→ 4,791,387 total
Holdings
- 220,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.80, inclusive. The reporting person undertakes to provide to the issuer, its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.